1. Home
  2. PD vs RLAY Comparison

PD vs RLAY Comparison

Compare PD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$6.20

Market Cap

636.9M

Sector

Technology

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.95

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
RLAY
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.9M
1.3B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PD
RLAY
Price
$6.20
$9.95
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$12.63
$16.86
AVG Volume (30 Days)
3.0M
2.3M
Earning Date
03-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
31.78
EPS
1.87
N/A
Revenue
$492,546,000.00
$15,355,000.00
Revenue This Year
$3.58
N/A
Revenue Next Year
$1.65
$324.03
P/E Ratio
$3.29
N/A
Revenue Growth
5.36
53.44
52 Week Low
$5.92
$1.78
52 Week High
$18.51
$11.49

Technical Indicators

Market Signals
Indicator
PD
RLAY
Relative Strength Index (RSI) 31.74 53.41
Support Level $6.17 $9.16
Resistance Level $16.47 $11.46
Average True Range (ATR) 0.43 0.63
MACD -0.02 -0.10
Stochastic Oscillator 16.25 31.24

Price Performance

Historical Comparison
PD
RLAY

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: